Drug delivery approaches for the treatment of glioblastoma multiforme

References

• Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD. 2009. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 18:1061–1083.
   PubMed Web of Science ®Google Scholar
• Albertazzi L, Gherardini L, Brondi M, Sulis Sato S, Bifone A, Pizzorusso T, et al. 2013. In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry. Mol Pharm. 10:249–260.
   PubMed Web of Science ®Google Scholar
• Anderson VC, Lenar DP, Quinn JF, Rooney WD. 2011. The blood-brain barrier and microvascular water exchange in Alzheimer’s disease. Cardiovasc Psychiatry Neurol. 2011:615829.
   PubMedGoogle Scholar
• Agarwal S, Manchanda P, Vogelbaum MA, Ohlfest JR, Elmquist WF. 2013. Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma. Drug Metab Dispos. 41:33–39.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Sane R, Oberoi R, Ohlfest JR, Elmquist WF. 2011. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev Mol Med. 13:e17.
   PubMed Web of Science ®Google Scholar
• Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, et al. 2006. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol. 177:5574–5584.
   PubMed Web of Science ®Google Scholar
• Bai CZ, Choi S, Nam K, An S, Park JS. 2013. Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma. Int J Pharm. 445:79–87.
   PubMed Web of Science ®Google Scholar
• Bazzoni G, Dejana E. 2004. Endothelial cell-to- cell junctions: Molecular organization and role in vascular homeostasis. Physiol Rev. 84:869–901.
   PubMed Web of Science ®Google Scholar
• Benny O, Pakneshan P. 2009. Novel technologies for antiangiogenic drug delivery in the brain. Cell Adh Migr. 3:224–229.
   PubMed Web of Science ®Google Scholar
• Bernacki J, Dobrowolska A, Nierwinska K, Malecki A. 2008. Physiology and pharmacological role of the blood-brain barrier. Pharmacol Rep. 60:600–622.
   PubMed Web of Science ®Google Scholar
• Bhujbal SV, de Vos P, Niclou SP. 2014. Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors. Adv Drug Deliv Rev. 67–68:142–153.
   PubMed Web of Science ®Google Scholar
• Blanchette M, Fortin D. 2011. Blood-brain barrier disruption in the treatment of brain tumors. Methods Mol Biol. 686:447–463.
   PubMedGoogle Scholar
• Bruce JN, Fine RL, Canoll P, Yun J, Kennedy BC, Rosenfeld SS, et al. 2011. Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery. 69:1272–1279
   PubMed Web of Science ®Google Scholar
• Buchwald P, Bodor N. 2001. A simple, predictive, structure-based skin permeability model. J Pharm Pharmacol. 53:1087–1098.
   PubMed Web of Science ®Google Scholar
• Chen PY, Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, et al. 2010. Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol. 12:1050–1060.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu L. 2012. Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev. 64:640–665.
   PubMed Web of Science ®Google Scholar
• Clayton J, Vloeberghs M, Jaspan T, Walker D, MacArthur D, Grundy R. 2008. Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration. Acta Neurochir (Wien). 150:709–712.
   PubMed Web of Science ®Google Scholar
• Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2014. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol.1–13.
   Web of Science ®Google Scholar
• de Robles P, Fiest KM, Frolkis AD, Pringsheim T, Atta C, St Germaine-Smith C, et al. 2014. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol. pii: nou283.
   PubMed Web of Science ®Google Scholar
• Emerich DF, Thanos CG. 2007. Targeted nanoparticle-based drug delivery and diagnosis. J Drug Target. 15:163–183.
   PubMed Web of Science ®Google Scholar
• Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, Yang HW, et al. 2010. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology. 255:415–425.
   PubMed Web of Science ®Google Scholar
• Fakhoury M, Coussa-Charley M, Al-Salami H, Kahouli I, Prakash S. 2014. Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn’s disease in mice. Curr Drug Deliv. 11:146–153.
   PubMed Web of Science ®Google Scholar
• Fakhoury M, Takechi R, Al-Salami H. 2015. Drug permeation across the blood-brain barrier: applications of nanotechnology. Br J Med Med Res. 6:547–556.
   Google Scholar
• Farhana SA, Shantakumar SM, Shyale S, Shalam M, Narasu L. 2010. Sustained release of verapamil hydrochloride from sodium alginate microcapsules. Curr Drug Deliv. 7:98–108.
   PubMedGoogle Scholar
• Ferrari M. 2005. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 5:161–171.
   PubMed Web of Science ®Google Scholar
• Fleischhack G, Reif S, Hasan C, Jaehde U, Hettmer S, Bode U. 2001. Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours. Br J Cancer. 84:1453–1459.
   PubMed Web of Science ®Google Scholar
• Folkman J. 2002. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 29:15–18.
   PubMed Web of Science ®Google Scholar
• Gong J, Chen M, Zheng Y, Wang S, Wang Y. 2012. Polymeric micelles drug delivery system in oncology. J Control Release. 159:312–323.
   PubMed Web of Science ®Google Scholar
• Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, et al. 2006. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res. 12: 1540–1546.
   PubMed Web of Science ®Google Scholar
• Hashizume R, Gupta N. 2010. Telomerase inhibitors for the treatment of brain tumors and the potential of intranasal delivery. Curr Opin Mol Ther. 12:168–175.
   PubMedGoogle Scholar
• Hashizume R, Ozawa T, Gryaznov SM, Bollen AW, Lamborn KR, Frey WH 2nd, Deen DF. 2008. New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163. Neuro Oncol. 10:112–20.
   PubMed Web of Science ®Google Scholar
• Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. 2011. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 14:219–248.
   PubMed Web of Science ®Google Scholar
• Hernández-Pedro NY, Rangel-López E, Magaña-Maldonado R, de la Cruz VP, del Angel AS, Pineda B, Sotelo J. 2013. Application of nanoparticles on diagnosis and therapy in gliomas. Biomed Res Int. 2013:351031.
   PubMed Web of Science ®Google Scholar
• Hosseini M, Haji-Fatahaliha M, Jadidi-Niaragh F, Majidi J, Yousefi M. 2015. The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy. Artif Cells Nanomed Biotechnol. 1–11.
   Google Scholar
• Huwyler J, Drewe J, Krähenbuhl S. 2008. Tumor targeting using liposomal antineoplastic drugs. Int J Nanomedicine. 3:21–29.
   PubMed Web of Science ®Google Scholar
• Inoue T, Yamashita Y, Nishihara M, Sugiyama S, Sonoda Y, Kumabe T, et al. 2009. Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against intracranial 9L brain tumor models. Neuro Oncol. 11:151–157.
   PubMed Web of Science ®Google Scholar
• Jain AK, Das M, Swarnakar NK, Jain S. 2011. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. Crit Rev Ther Drug Carrier Syst. 28:1–45.
   PubMed Web of Science ®Google Scholar
• Jin Y, Li J, Rong LF, Lü XW, Huang Y, Xu SY. 2005. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice. Acta Pharmacol Sin. 26:250–256.
   PubMed Web of Science ®Google Scholar
• Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Dunn IF, et al. 2001. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol. 19:35–39.
   PubMed Web of Science ®Google Scholar
• Kaur P, Garg T, Rath G, Goyal AK. 2015. In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane. Artif Cells Nanomed Biotechnol. 1–10.
   Google Scholar
• Kesari S. 2011. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments. Semin Oncol. 38:2–10.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim JS, Cho WK, Hwang SJ. 2013. Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles. Artif Cells Nanomed Biotechnol. 41:85–91.
   PubMed Web of Science ®Google Scholar
• Kolosnjaj J, Szwarc H, Moussa F. 2007. Toxicity studies of carbon nanotubes. Adv Exp Med Biol. 620:181–204.
   PubMed Web of Science ®Google Scholar
• Koziara JM, Lockman PR, Allen DD, Mumper RJ. 2004. Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release. 99:259–269.
   PubMed Web of Science ®Google Scholar
• Kushnir I, Tzuk-Shina T. 2011. Efficacy of treatment for glioblastoma multiforme in eldery patients (65+): a retrospective analysis. Isr Med Assoc.13:290–294.
   PubMed Web of Science ®Google Scholar
• Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G. 2009. New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv. 6:1017–1032.
   PubMed Web of Science ®Google Scholar
• Lopez KA, Waziri AE, Canoll PD, Bruce JN. 2006. Convection-enhanced delivery in the treatment of malignant glioma. Neurol Res. 28:542–548.
   PubMed Web of Science ®Google Scholar
• Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. 2011. A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine. 6:2963–2979.
   PubMed Web of Science ®Google Scholar
• Martinez-Quintanilla J, Bhere D, Heidari P, He D, Mahmood U, Shah K. 2013. Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors. Stem Cells. 31:1706–1714.
   PubMed Web of Science ®Google Scholar
• Mishra SS, Behera SK, Dhir MK, Senapati SB. 2014. Cerebellar giant cell glioblastoma multiforme in an adult. J Neurosci Rural Pract. 5:295–297
   PubMedGoogle Scholar
• Misra A, Ganesh S, Shahiwala A, Shah SP. 2003. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 6: 252–273.
   PubMed Web of Science ®Google Scholar
• Miura Y, Takenaka T, Toh K, Wu S, Nishihara H, Kano MR, et al. 2013. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. ACS Nano. 7:8583–8592.
   PubMed Web of Science ®Google Scholar
• Molenaar RJ. 2011. Ion channels in glioblastoma. ISRN Neurol. 2011:590249.
   PubMedGoogle Scholar
• Morshed RA, Cheng Y, Auffinger B, Wegscheid ML, Lesniak MS. 2013. The potential of polymeric micelles in the context of glioblastoma therapy. Front Pharmacol. 4:157.
   PubMed Web of Science ®Google Scholar
• Murua A, Portero A, Orive G, Hernández RM, de Castro M, Pedraz JL. 2008. Cell microencapsulation technology: towards clinical application. J Control Release. 132:76–83.
   PubMed Web of Science ®Google Scholar
• Negrulj R, Mooranian A, Chen-Tan N, Al-Sallami HS, Mikov M, Golocorbin-Kon S, et al. 2015. Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes. Artif Cells Nanomed Biotechnol. 1–8.
   Google Scholar
• Nelson SJ, Cha S. 2003. Imaging glioblastoma multiforme. Cancer J. 9:134–145.
   PubMed Web of Science ®Google Scholar
• Ochiai H, Campbell SA, Archer GE, Chewning TA, Dragunsky E, Ivanov A, et al. 2006. Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus. Clin Cancer Res. 12:1349–1354.
   PubMed Web of Science ®Google Scholar
• Ohgaki H, Kleihues P. 2013. The definition of primary and secondary glioblastoma. Clin Cancer Res. 19:764–772.
   PubMed Web of Science ®Google Scholar
• Onishi M, Kurozumi K, Ichikawa T, Date I. 2013. Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme. Neurol Med Chir (Tokyo). 53:755–763.
   PubMed Web of Science ®Google Scholar
• Orive G, Anitua E, Pedraz JL, Emerich DF. 2009. Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci. 10:682–692.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. 2005. The blood-brain barrier and neurotherapeutics. NeuroRx. 2:1–2.
   PubMedGoogle Scholar
• Pardridge WM. 2012. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 32:1959–1972
   PubMed Web of Science ®Google Scholar
• Park SS, Chunta JL, Robertson JM, Martinez AA, Oliver Wong CY, Amin M, et al. 2011. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation. Int J Radiat Oncol Biol Phys. 80:885–892.
   PubMed Web of Science ®Google Scholar
• Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF. 2009. Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs. 23:35–58.
   PubMed Web of Science ®Google Scholar
• Perlstein B, Ram Z, Daniels D, Ocherashvilli A, Roth Y, Margel S, Mardor Y. 2008. Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring. Neuro Oncol. 10:153–161.
   PubMed Web of Science ®Google Scholar
• Ramirez YP, Weatherbee JL, Wheelhouse RT, Ross AH. 2013. Glioblastoma multiforme therapy and mechanisms of resistance. Pharmaceuticals (Basel). 6:1475–506.
   PubMedGoogle Scholar
• Rastogi V, Yadav P, Bhattacharya SS, Mishra AK, Verma N, Verma A, Pandit JK. 2014. Carbon nanotubes: an emerging drug carrier for targeting cancer cells. J Drug Deliv. 2014:670815.
   PubMedGoogle Scholar
• Reilly KM. 2009. Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk. Brain Pathol. 19:121–131.
   PubMed Web of Science ®Google Scholar
• Ren J, Shen S, Wang D, Xi Z, Guo L, Pang Z, et al. 2012. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2. Biomaterials. 33:3324–3333.
   PubMed Web of Science ®Google Scholar
• Ren Y, Zhou X, Mei M, Yuan XB, Han L, Wang GX, et al. 2010. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer. 10:27.
   PubMed Web of Science ®Google Scholar
• Sathornsumetee S, Rich JN. 2006. New approaches to primary brain tumor treatment. Anticancer Drugs. 17:1003–1006.
   PubMed Web of Science ®Google Scholar
• Sathornsumetee S, Rich JN, Reardon DA. 2007. Diagnosis and treatment of high-grade astrocytoma. Neurol Clin. 25:1111–1139
   PubMed Web of Science ®Google Scholar
• Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. 2006. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2:494–503.
   PubMedGoogle Scholar
• Scott AW, Tyler BM, Masi BC, Upadhyay UM, Patta YR, Grossman R, et al. 2011. Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model. Biomaterials. 32:2532–2539.
   PubMed Web of Science ®Google Scholar
• Serwer LP, James CD. 2012. Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations. Adv Drug Deliv Rev. 64:590–597.
   PubMed Web of Science ®Google Scholar
• Shingaki T, Inoue D, Furubayashi T, Sakane T, Katsumi H, Yamamoto A, Yamashita S. 2010. Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy. Mol Pharm. 7:1561–1568.
   PubMed Web of Science ®Google Scholar
• Shahideh M, Fallah A, Munoz DG, Loch Macdonald R. 2012. Systematic review of primary intracranial glioblastoma multiforme with symptomatic spinal metastases, with two illustrative patients. J Clin Neurosci. 219:1080–1086.
   Web of Science ®Google Scholar
• Singh PK, Singh VK, Tomar J, Azam A, Gupta S, Kumar S. 2009. Spinal glioblastoma multiforme: unusual cause of post-traumatic tetraparesis. J Spinal Cord Med. 32:583–586.
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW Jr. 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 86:215–223.
   PubMed Web of Science ®Google Scholar
• Sizoo EM, Braam L, Postma TJ, Pasman HR, Heimans JJ, Klein M, et al. 2010. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol. 12:1162–1166.
   PubMed Web of Science ®Google Scholar
• Sood S, Jain K, Gowthamarajan K. 2014. Intranasal therapeutic strategies for management of Alzheimer’s disease. J Drug Target. 22: 279–294.
   PubMed Web of Science ®Google Scholar
• Stark AM, Maslehaty H, Hugo HH, Mahvash M, Mehdorn HM. 2010. Glioblastoma of the cerebellum and brainstem. J Clin Neurosci. 17:1248–1251.
   PubMed Web of Science ®Google Scholar
• Tate MC, Aghi MK. 2009. Biology of angiogenesis and invasion in glioma. Neurotherapeutics. 6:447–457.
   PubMed Web of Science ®Google Scholar
• Tavakolifard S, Biazar E, Pourshamsian K, Moslemin MH. 2015. Synthesis and evaluation of single-wall carbon nanotube-paclitaxel-folic acid conjugate as an anti-cancer targeting agent. Artif Cells Nanomed Biotechnol.1–7.
   PubMed Web of Science ®Google Scholar
• Tripathi RM, Shrivastav A, Shrivastav BR. 2014. Biogenic gold nanoparticles: As a potential candidate for brain tumor directed drug delivery. Artif Cells Nanomed Biotechnol.1–7.
   Web of Science ®Google Scholar
• Upadhyay RK. 2014. Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int. 2014:869269.
   PubMed Web of Science ®Google Scholar
• Vyas TK, Shahiwala A, Marathe S, Misra A. 2005. Intranasal drug delivery for brain targeting. Curr Drug Deliv. 2:165–175.
   PubMedGoogle Scholar
• Wen PY, Kesari S. 2008. Malignant gliomas in adults. N Engl J Med. 359:492–507.
   PubMed Web of Science ®Google Scholar
• Wong ET, Brem S. 2008. Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities. J Natl Compr Canc Netw. 6:515–522.
   PubMedGoogle Scholar
• Wu G, Barth RF, Yang W, Kawabata S, Zhang L, Green-Church K. 2006. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Mol Cancer Ther. 5:52–59.
   PubMed Web of Science ®Google Scholar
• Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, et al. 2011. Angiopep- conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials. 32:4293–4305.
   PubMed Web of Science ®Google Scholar
• Yun J, Rothrock RJ, Canoll P, Bruce JN. 2013. Convection-enhanced delivery for targeted delivery of antiglioma agents: the translational experience. J Drug Deliv. 2013:107573.
   PubMedGoogle Scholar
• Zhang W, Zhang Z, Zhang Y. 2011. The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res Lett. 6:555.
   PubMed Web of Science ®Google Scholar
• Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng MQ, Duong N, et al. 2013. Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci USA. 110:11751–11756.
   PubMed Web of Science ®Google Scholar